![]() ![]() Identifying the main gaps: EMA baseline report Trends in science and technology Trends in Regulatory Science tools Therapeutic area diseases Access pathways Oncology/CNS neurodegenerative diseases Diabetes/ Obesity/ HIV/ Vaccines/ Immunotherapies PRIME/ Adaptive pathways/ Biosimilars Gene therapy and regenerative medicine Gene therapy/ cells and tissues based products New materials Personalised medicines HTAs’ and Payers’ collaborative activities Synergies with HTA/payers activities Non-clinical methodology Novel non-clinical models Personalised medicine/ Biomarkers Clinical methodology Methods, technologies and other trends Modelling and simulation/ Extrapolation Patient reported outcomes (PROs)/ New endpoints Bayesian methods Nanotechnology/ New Omics (e.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |